Maria Socorro O Portella

Statistics

Publications

Citations

513

H-Index

Active since

2017

Affiliations

Chinese University of Hong Kong(Current)

Tel Aviv Sourasky Medical Center

Prince of Wales Hospital

Tel Aviv University

Novartis (Switzerland)

Maria Socorro O Portella is an author at Chinese University of Hong Kong specializing in pharmacotherapy, refractory thrombocytopenia management, and hematologic malignancy therapy.

Publications per year

2017–2018

Publications

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study

Raymond Wong, Mansoor N. Saleh, Abderrahim Khélif et al. · Blood · 2017 · 310 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +2

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial

Moshe Mittelman, Uwe Platzbecker, Boris V. Afanasyev et al. · The Lancet Haematology · 2017 · 107 citations

Medicine, Hematology, Pharmacology +15

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Michael Dickinson, Honar Cherif, Pierre Fenaux et al. · Blood · 2018 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

1–3 of 3